Digital RESI JPM, January 11-13, 2022

11 AM EST – Medical Devices Investor Panel

Bringing the Next Generation of Medical Devices to Market

Investing in medical devices has become more complex with time. While standard medical devices are still a mainstay, there are an increasing amount of combination devices, software-enabled devices and diagnostic devices that require investors to have expertise in multiple sectors. Panelists may discuss topics such as:

  • The benefits vs. risks of devices that cross sectors
  • Regulatory challenges
  • Amount/type of data they want to see before investing

Panelists will discuss how to meet the challenges of raising financing for a new device and advise startups on how to make the investment case for their novel technology. Panelists will also explore what technology areas are of top interest to them and how a startup can make themselves stand out in the crowd.

2 PM EST – The Regulatory Pathway for AI in Healthcare Panel

Navigating the Process with Strategic Partners

Whatever the business model, the regulatory road for AI technology can be long, winding, and unpredictable. However, the right partners will be an asset to the process and beyond. Learn how to discuss your progress and projections with current and potential investors, and even how to incorporate the regulatory risks into your pitch.

3 PM EST – Big Pharma Panel

Pipeline Strategy for Preclinical and Early Clinical Assets

In recent years, big pharma companies have begun looking outwards for innovative new therapeutics to add to their pipelines. This panel brings together speakers from various big pharma companies discussing topics such as:

  • How big pharma sources assets
  • The evaluation and investment process
  • Key factors of interest
  • How early-stage big pharma is willing to look

These panelists will shed light on the process that big pharma goes through when sourcing early-stage assets and advise startups on how they can best make a case for themselves. Panelists will also explore various trends within the therapeutics marketplace, what assets are of interest to their company, and what they think will be big in the future.

4 PM EST – Tales from the Road: Age-Tech Innovators on their Fundraising Journey

Age-tech entrepreneurs are pounding the pavement, seeking funding to enable seniors to live longer, healthier lives. Learn the strategies they’ve implemented to stand out to investors, book meetings, make deals, and work effectively with investors and strategic partners.

5 PM EST – Longevity Investors Share Their Investment Thesis

Who is investing in the longevity market? What are the priorities of corporate, venture, seed and angel investors. What are some of the successful growth stories. Who has been funded from RESI.

10 AM EST – Family Offices Panel

How Do Family Offices View Seed & Series A Rounds?

This panel focusing on understanding how family offices view direct investments in early-stage healthcare opportunities (seed – series A) and how the differ/compare to VCs. Topics may include:

  • Primary differences between institutional VCs and family office investors
  • How family offices source investments / how to get on their radar
  • Trends in the early-stage healthcare investment space

The primary goal of this panel is to help entrepreneurs understand how family offices view early-stage investments in the healthcare space and best practices for approaching, pitching and working with these groups as well as debunking some common misconceptions about family offices.

11 AM EST – Defining and Funding Age-Tech Innovations Panel

Using the Language that Speaks to Investors

Age-tech, longevity, healthy aging, healthtech, elderly care, senior care, etc… the terms are vast in this sector of the life sciences. Early-stage companies specializing in the aging industry can define themselves in many ways. What definitions are investors looking for? And the importance of pliability in your definition in an industry that is always morphing.

2 PM EST – Digital Health Investor Panel

Leveraging Software to Lower Costs and Improve the Quality of Care

This panel focuses on investing in innovative digital health products that bring new efficiencies to the healthcare system, change how care is delivered or managed, and how patients are involved in their own care. Panelists will explore topics related to investing in digital health, including:

  • In what kinds of digital health technologies are they interested in investing?
  • What metrics and evidence do you look for in a digital health startup?
  • How can an early stage digital health company demonstrate the value of their products?
  • What are the main challenges for startups raising capital in this space?

The moderator and panelists will discuss this rapidly evolving field of healthcare investment, and will introduce the audience to the key fundraising opportunities and challenges facing digital health entrepreneurs today.

3 PM EST – The Early-Stage Pivot Panel

Switching Directions with AI Technology

The opportunities for AI applications within life science and healthcare are innumerable and the need only increases. With so many options available to the early-stage entrepreneur, how do they know when it’s time to pivot the company or expand beyond their offerings? How do they approach potential pivots when fundraising or working with their current investors? Learn how to discuss early-stage pivots with partners, accept feedback, and how to be both steady and flexible while at the helm of the ship.  

4 PM EST – Tales from the Road: Biotech and MedTech Innovators on their Fundraising Journey

The industry has quickly adapted to a “new normal” – entrepreneurs and investors meet virtually over digital platforms to discuss potential investment opportunities, and it is not uncommon to see entrepreneurs raise capital from investors they have never met before in person. That said, there is no doubt that the fundraising journey continues to be challenging for many. In this panel, you will be able to hear fellow entrepreneurs share their experiences, from successes to challenges. This panel will discuss the following topics and more: 

  • What are some of the greatest challenges entrepreneurs have faced, especially during the pandemic, and how were they overcome?
  • How did entrepreneurs identify investors that fit their technology?
  • What are some misconceptions entrepreneurs had about the early-stage investment landscape?

Furthermore, entrepreneurs will share unique tips and insights they have gained from their fundraising experiences, and how others can work their way towards a more successful campaign.

5 PM EST – Longevity Entrepreneurs Discuss Their New Products

Six entrepreneurs building business in the longevity market will share their vision, team and concept and the traction they are getting in the market. Topics will cover cognitive fitness and memory loss, mobility, aging in place, staffing and online learning and training.

11 AM EST – Diagnostics Panel

New Generation of Technologies Changing Treatment Paradigms

This panel focuses on investments in innovative diagnostics, ranging from IVD, genomics, precision medicine, and more. Topics may include:

  • Current areas of interest
  • Current challenges in this ecosystem – Navigating the competitive landscape
  • Commonly observed red flags
  • Successful deals

Panelists will discuss how companies can successfully fundraise for their budding diagnostics technology and the best way to successfully approach and develop a relationship with relevant investors. Panelists will also explore current areas of interest and why they are relevant, as well as developmental and regulatory hurdles and how companies can address these problems to attain key milestones.

2 PM EST – Emerging Products and Technologies for Aging at Home Panel

New Products and Technologies Emerge in the Aging at Home Arena

Seniors today are prioritizing the ability to live well where they choose. The aging baby boomer generation and the ongoing Covid 19 pandemic have emphasized the opportunities and the technology is inventive. Learn more about what life science investors are seeing as important trends in this popular space.

3 PM EST – Corporate VC Panel

Novel Approaches on Corporate Innovation & Their Value-Add

Corporate venture capital firms are an important source of capital for early-stage companies. Many major pharmaceuticals and large corporations have set up a corporate investment arm to identify early-stage companies. Strategically and financially driven in varying degrees, the implications of working with CVCs are huge, as the resources, network, and guidance provided by the CVC and the associated parent company are incredibly valuable to an entrepreneur who is actively growing their business.

This panel will discuss the following topics and more:

  • How are CVCs different from traditional VCs?
  • How strategically vs. financially are CVCs driven, and how does this affect their decision-making process?
  • How closely does the CVC communicate with the parent company?
  • What does working with a CVC entail?

Panelists will discuss each of their investment mandates and how they relate to corporate interests, and how they have been sourcing opportunities during COVID. Panelists may also explore current trending areas of interest, and what they see as emerging fields in the near future.

4 PM EST – Tales from the Road: AI Innovators on their Fundraising Journey

Hear from fundraising entrepreneurs on their processes researching, pitching, and working with investors. AI technology has incredible potential in healthcare, but also raises unique challenges. Hear from founders on how AI fits into their story and solutions, and how they sourced the right investors for them.